Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
If you trust your patient to manage their insulin, Jervey said, you can trust them to pick up one of these new medications with the proper education. Learn more about research for new type 1 diabetes treatments:
Clinical Trials for Incretin-Based Therapy Highlighting the medications healthcare professionals can expect to see coming into the pipeline this year and next, Donna Ryan, MD, Professor Emeritus, Clinical Science, Pennington Biomedical Research Center at Louisiana State University, Baton Rouge, shared a robust overview of clinical trial data, including results from OASIS 1 and 4, STEP UP, and REDEFINE 1 and 2, reflecting the options and opportunities to better inform clinical decision-making
The diabetes and obesity market is expanding rapidly, with GLP-1 agonists a key medication that is proven to lower blood sugar levels, they also suppress appetite and reduce calorie intake
Published 2014 Oct 30
More structural improvementssuch as tendon integrity and joint stabilitytypically develop over 8-16 weeks
US$ 23.89
US$ 22.51
US$ 23.01
US$ 27.02
